Dear Friends & Colleagues,
It is our pleasure to invite you to The 3rd International Congress on Precision Medicine which will take place on 29-30 October 2020, in Munich, Germany.
We would like to take the opportunity to thank all attendees, supporters and sponsors of last year’s event for contributing to the success of PMBC2019. Based on the overwhelmingly positive feedback we will continue to focus on interdisciplinary, workshop like sessions and forward looking constructive discussions to foster Precision Medicine.
Today, Precision Medicine is still lagging behind in diseases with the highest socioeconomic impact. In fact, there is a growing number of immune-mediated inflammatory diseases (IMIDs). Global Immune-Mediated Inflammatory Diseases (IMIDs) treatment market may further increase to CAGR of 6.3% in 2025. In addition, the aging populations around the world with further increase the pressure on society to creatively tackle the triple trillion US$ healthcare market with IMIDs and aging becoming an increasing challenge also in BRIC region.
At the same time, data sciences in conjunction with multiomics, RWD, learnings from immune-oncology, microbiome, nanobiology, CRISPR etc will allow the generation of new insight and concepts to tackle global disease burden and eventually deliver Precision Medicine.
PMBC2020 aims to identify and direct R&D in industry and academia towards actionable insights and the generation of flagship projects doable today to address tomorrow’s challenges.
With these contentions in mind the biomedical community and all stakeholders in medicine & healthcare are invited to join constructive and engaging discussions in Munich that will eventually lead to better serving customers true needs already today, but definitely tomorrow by providing Precision Medicine and Precision Health.
This year PMBC2020 will take place directly after BioEurope Munich (26-28 October).
We look forward to welcoming you in Munich once again!
Dr. Thomas Wilckens
Prof. Dr. Horst Domdey